Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Chinese drugmaker Innogen expects to complete a late-stage clinical trial of its experimental weight-loss drug candidate next ...

The Dalai Lama said on Wednesday the institution of the Dalai Lama will continue and the Gaden Phodrang trust has sole ...

A new scientific study into the weight loss drug Mounjaro has found that it may not lead to a worrying side effect as ...

The country’s Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, the UK’s official system for ...

Weight loss injections promise quick results, but skipping blood screening can trigger serious risks like pancreatitis or ...

High-profile Ozempic users such as Sharon Osbourne, Whoopi Goldberg, and Rebel Wilson have publicly endorsed the medication ...

India is stepping into the billion-dollar weight-loss drug war! With Wegovy and Mounjaro already here, Biocon is quietly ...

GLP-1 drugs like Ozempic may have much more serious, and even potentially deadly, side effects than originally thought.

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

The incidence of obesity and diabetes is rising in India, the world’s most populous country, which also ranks among the worst ...